Chemical Peel

A chemical peel is not a treatment chosen by asking which acid is strongest.

It is a controlled chemical injury.

An exfoliating agent is applied to the skin with the intention of producing a predictable depth of epidermal and, in selected treatments, dermal injury. The tissue then heals through re-epithelialisation and remodelling.

The word acid can make the procedure sound like one chemical family delivered at different percentages.

That is not how chemical peeling works.

Glycolic acid, salicylic acid, trichloroacetic acid, Jessner-type combinations and phenol do not behave identically. Their penetration, chemical behaviour and clinical indications differ. Concentration matters, but so do formulation, pH, skin preparation, application technique, contact behaviour and the patient’s skin.

This is why I start with depth rather than product popularity: what layer contains the problem, what degree of controlled injury is required to influence it, and how much inflammatory risk is reasonable for this particular skin?

A chemical peel should be defined by the injury it creates

The visible solution applied to the face is only the beginning of the treatment.

What matters clinically is how far its effect extends into the tissue.

A superficial peel primarily acts within the epidermis. It can accelerate epidermal turnover and influence selected acne, superficial pigmentation and textural concerns while generally allowing relatively rapid recovery.

A medium-depth peel creates a more substantial injury extending into the upper dermis. That increases its ability to influence selected photodamage, pigment and fine structural change, but also increases recovery and complication risk.

A deep peel goes further again and belongs to a different medical category.

Peel depth is not a quality scale.

The correct peel is not the deepest peel the patient can tolerate. It is the shallowest injury capable of reaching the problem we have decided to treat.

Concentration alone does not tell me how deep a peel will behave

Patients often compare peels using percentage.

A higher number appears stronger, and therefore more effective.

That is an incomplete way to understand chemical treatment.

The biological effect of an acid depends on more than the concentration written on the bottle. pH can substantially influence the amount of free acid available. The vehicle changes delivery. Skin preparation alters penetration. Degreasing, repeated coats, contact time and regional skin thickness can all change the effective treatment.

Different acids also behave differently even when their percentages look similar.

I therefore do not compare a salicylic peel with a glycolic peel by asking which number is larger.

The chemistry has to be understood before the number means anything.

Glycolic acid is useful because it allows relatively controlled superficial resurfacing

Glycolic acid is an alpha-hydroxy acid and one of the most widely studied superficial peeling agents.

It is water soluble and can be used for selected epidermal pigmentation, acne-related changes, rough texture and aspects of photoaging.

Its clinical value comes partly from flexibility.

A relatively conservative protocol can produce modest epidermal renewal with limited downtime, while more intensive use increases the biological effect.

That does not mean escalation should occur automatically.

If a patient’s main problem is mild surface irregularity or pigment, there is little advantage in increasing irritation simply because the skin tolerated the previous treatment.

Tolerance is not the same thing as indication.

Salicylic acid occupies a useful position in oily and acne-prone skin

Salicylic acid is lipid soluble.

That characteristic makes it particularly relevant to the pilosebaceous environment and helps explain its long-standing role in acne-prone and oily skin.

It can influence keratinisation and superficial comedonal congestion while also providing anti-inflammatory effects.

This makes it a coherent choice in selected patients whose problem sits largely around follicular and epidermal biology.

I still do not treat every acne patient with a peel.

Inflammatory acne is a disease process. A peel may support the treatment plan, but persistent papules, pustules, nodules or scarring disease can require medical therapy capable of controlling the process that continues creating new lesions.

The peel should improve the acne plan.

It should not become a reason to postpone the treatment that active acne actually requires.

Jessner-type peels are combinations, not one universal formula

The name Jessner’s solution is familiar in aesthetic dermatology, but several modern formulations and modified versions exist.

Combination formulations can use ingredients with different keratolytic and exfoliative properties to produce a more controlled or enhanced superficial effect.

This can be useful.

It also means the treatment should be identified by what the formulation actually contains rather than assuming that every product labelled Jessner behaves identically.

I want the chemistry known before I use the historical name as shorthand.

Trichloroacetic acid becomes a different treatment as depth increases

TCA has a long history in chemical peeling because its tissue effect can be clinically visible and relatively predictable when used by experienced physicians.

It causes protein coagulation within the treated tissue.

At superficial treatment levels, it can influence epidermal irregularity and selected pigmentary concerns.

At greater effective depths, it moves into medium-depth resurfacing with more substantial wound healing and recovery.

This is exactly why I do not discuss TCA as though it were simply another lunchtime peel.

The same chemical name can sit in different procedural categories depending on how the treatment is designed.

As depth increases, so do the consequences of imprecision.

Frost is a clinical sign, not an achievement

TCA and some other peeling protocols can produce visible whitening or frosting as proteins coagulate.

The pattern and intensity can help an experienced clinician assess tissue response.

This visible endpoint has unfortunately become part of the theatre of chemical peeling.

Patients see a white face and assume the peel has reached a more powerful level of rejuvenation.

That is the wrong interpretation.

The frost is information.

It tells us something about what the chemical has done.

Once the intended tissue response has been reached, pursuing a more dramatic frost simply increases injury.

The endpoint is not the whitest skin during the procedure.

The endpoint is the correct depth after the skin has healed.

Phenol peeling belongs to a different risk category

Deep phenol peeling can produce substantial improvement in selected severe photoaging and deep rhytids.

It is also a treatment whose risk extends beyond the skin.

Phenol can be systemically absorbed, and cardiotoxicity is a well-established concern. Renal and hepatic considerations, prolonged healing, pigment changes and scarring also make deep phenol peeling fundamentally different from a routine superficial facial peel.

I therefore do not position phenol as the final step in a sequence that begins with glycolic acid.

It is not simply what happens when a patient wants a stronger peel.

It is a deeper medical resurfacing procedure requiring a much higher indication threshold, appropriate monitoring and careful patient selection.

More dramatic rejuvenation comes with a larger wound

This relationship is unavoidable.

Deeper chemical injury can remove more abnormal epidermal tissue and stimulate more substantial remodelling.

The price is greater disruption of the normal skin barrier and a longer period during which healing can go wrong.

Persistent erythema, infection, herpes reactivation, hyperpigmentation, hypopigmentation and scarring become more important as depth increases.

This is why downtime should never be described as a nuisance separate from efficacy.

Downtime reflects the biological scale of the intervention.

If the patient is unwilling or unable to manage the healing process required by a deeper peel, the treatment itself may be inappropriate regardless of how attractive the expected result appears.

Acne and post-acne pigmentation can respond to the same superficial peel for different reasons

An acne-prone patient may have active comedonal disease and residual dark marks from previous inflammation.

A selected superficial peel can influence follicular keratinisation while also accelerating epidermal turnover and improving some superficial pigment.

This makes chemical peeling useful as an adjunct because two related but distinct concerns may improve together.

But the sequence still matters.

If inflammatory acne remains uncontrolled, new pigmentation will continue appearing.

I do not want to spend months peeling yesterday’s marks while untreated disease keeps creating tomorrow’s marks.

Post-inflammatory pigmentation is exactly where excessive peeling can defeat itself

PIH develops because melanocytes respond to inflammation.

A chemical peel deliberately creates inflammation.

This creates an obvious clinical tension.

A sufficiently controlled superficial peel can improve selected epidermal pigment.

An excessive peel can provoke a new pigmentary response that is darker and more persistent than the original concern.

This risk becomes particularly important in darker and highly pigment-reactive skin.

The treatment therefore has to do enough to alter the unwanted pigment while staying below the inflammatory threshold at which the skin creates another pigment problem.

A pigmentation treatment that creates more pigmentation has crossed its useful dose.

Skin of colour can be peeled successfully, but the margin for unnecessary inflammation is smaller

I do not treat darker Fitzpatrick skin types as a blanket contraindication to chemical peeling.

Recent reviews support the use of selected superficial glycolic and salicylic acid peels in skin of colour, particularly for acne and pigment-related concerns.

What changes is the risk calculus.

PIH is more likely to be visible and persistent after excessive inflammation. Hypopigmentation and demarcation can also become more consequential.

This is why I favour conservative depth, stable baseline skin, photoprotection and enough recovery between treatments to understand how that patient’s pigment system responded.

The aim is not equal treatment settings across all skin tones.

The aim is equal seriousness about the outcome.

Melasma can improve with chemical peels without becoming a peel disease

Recent systematic review evidence supports chemical peeling as an effective adjunctive option in melasma, with glycolic acid among the most established agents.

I still view the word adjunctive as important.

Melasma is chronic and relapsing. Ultraviolet exposure, visible light, hormonal influences and melanocyte reactivity continue after the peel.

Removing superficial pigment does not remove that biological tendency.

Photoprotection and topical pigment control generally remain central.

A peel can accelerate improvement in the right patient.

I do not want repeated chemical injury to become the only long-term strategy for a disorder whose biology is easily provoked by inflammation.

A stronger melasma peel can produce a weaker long-term plan

There is a psychological appeal to seeing visible peeling when treating pigment.

It looks as though the unwanted colour is physically leaving the face.

Melasma does not behave that simply.

Excessive injury can activate melanogenesis and create PIH on top of the original disorder.

The successful treatment is therefore often less dramatic than the patient expects.

Long-term pigment stability matters more than the amount of epidermis visible on a towel during the first week.

Fine lines can improve when the line contains a skin-quality component

Chemical resurfacing can soften selected fine static lines by renewing epidermal architecture and, with deeper treatment, influencing dermal remodelling.

That does not make chemical peeling equivalent to neuromodulation.

A forehead crease created repeatedly by strong frontalis activity has a muscular mechanism.

A deep fold associated with structural facial ageing contains another layer again.

Peeling can improve the skin component.

It cannot prevent the muscle from recreating the fold or reposition descended tissue.

I want the patient to understand what fraction of the line actually belongs to the peel.

Acne scars should not be grouped together because some peels can improve some scars

Chemical techniques have important roles in scar treatment.

But the correct technique depends heavily on architecture.

Broad superficial irregularity can improve through resurfacing. Selected narrow deep scars may be treated using focal chemical reconstruction rather than full-face peeling. Tethered rolling scars require another mechanical consideration entirely.

This is why I do not increase full-face peel depth simply because deeper acne scars remain.

The residual scar may require a different distribution of treatment, not a stronger injury to every square centimetre of normal surrounding skin.

A focal chemical treatment and a full-face chemical peel are not the same procedure

A scar-specific chemical technique can deliberately deliver a stronger effect to one tiny structural target while leaving most surrounding skin untreated.

A full-face peel exposes a much larger surface area.

The total biological burden and complication profile are therefore different.

This is another reason procedure names need precision.

Knowing that TCA was used does not tell me what treatment actually happened.

Barrier instability is a reason to delay the peel

A patient may arrive with redness, burning and flaking after combining retinoids, acids, scrubs and several active products.

They sometimes interpret that irritation as evidence that the skin is ready to shed and therefore a professional peel will complete the process.

I interpret it differently.

The barrier is already signalling excessive injury.

Adding another controlled injury to tissue that has lost control of its baseline inflammation makes the result less predictable.

I would rather restore stability first and reassess what problem remains.

Sometimes the patient discovers that the dullness or roughness they wanted peeled was itself caused by over-treatment.

Preparation should reduce uncertainty rather than make the skin artificially tolerant of a predetermined peel

Pre-treatment skincare may be used to stabilise pigment, improve epidermal turnover or reduce specific complication risks depending on the patient and planned peel.

I think the principle is more important than one universal protocol.

Preparation should make the treatment safer and the response more predictable.

It should not become a ritual performed identically before every acid regardless of skin type, indication or depth.

Herpes history matters when facial resurfacing disrupts the epidermis

Procedural trauma can reactivate herpes simplex in susceptible patients.

The relevance increases with more substantial facial resurfacing and particular perioral treatment patterns.

A history of recurrent cold sores therefore belongs in the medical assessment before peeling.

Depending on treatment depth and clinical context, prophylaxis may be considered rather than waiting for a preventable outbreak to complicate wound healing.

Photoprotection begins before the peel has finished healing

Freshly resurfaced skin is particularly vulnerable to ultraviolet-driven inflammation and pigmentation.

This makes post-peel sun behaviour part of the procedure.

If a patient intends to spend the following week in intense sun, the best peel may be the one postponed to another date.

No acid formulation can compensate for an aftercare environment that actively increases pigment risk while the epidermis is recovering.

The patient should not manually accelerate peeling

Visible flakes can create the temptation to scrub, pick or pull away skin.

That converts controlled exfoliation into uncontrolled trauma.

Premature mechanical removal can create focal inflammation, erosions and subsequent pigmentation.

The treatment was designed around the tissue separating on its own schedule.

Recovery should not become a second procedure performed by the patient in the bathroom mirror.

Repeated superficial peels can be more rational than one deeper peel

For selected conditions, particularly acne and superficial pigmentation, a staged superficial course can gradually improve the skin while preserving a relatively low recovery burden.

This can be an excellent strategy.

But repetition should not become automatic either.

If the patient reaches a stable satisfactory result, another peel is not biologically required because a package contains two unused sessions.

If progress stops because the remaining problem lies deeper, repeating the same superficial treatment indefinitely may also become inefficient.

Staging is useful when each treatment still has something useful to change.

Laser and peel should be compared by problem rather than by technology

Both laser resurfacing and chemical peeling can improve photoaging, texture and selected pigmentation.

Recent comparative meta-analysis suggests that both can produce meaningful improvement, with no universal superiority across all dermatological indications.

That is clinically intuitive.

A laser offers wavelength-, depth- and fractional-delivery options that a chemical cannot reproduce.

A peel can create broad controlled resurfacing without requiring an energy platform.

The correct question is not whether modern laser technology has replaced chemical peels.

It is which treatment gives the required biological effect with the most favourable recovery and risk profile for this skin.

What a good chemical-peel result means to me

I want a more uniform skin surface after complete healing.

Selected superficial pigmentation may become lighter. Comedonal congestion can improve. Rough texture and aspects of photodamage may become less obvious. Appropriate deeper treatment can produce more substantial resurfacing in carefully selected patients.

I do not judge success by the amount of skin that visibly peeled.

I do not expect a chemical peel to lift a jowl or replace structural facial treatment.

And I do not accept months of new PIH as a reasonable price for several days of dramatic exfoliation.

The successful peel is the one whose final improvement is larger than the inflammatory footprint required to create it.

When chemical peeling makes sense to me

I am most comfortable recommending a chemical peel when the problem is genuinely accessible through epidermal or controlled dermal resurfacing and when the skin is stable enough to heal predictably.

Superficial peels can be particularly coherent for selected acne, post-inflammatory pigmentation, melasma as part of a broader plan and early photoaging.

Medium-depth treatment requires a larger indication and recovery commitment.

Deep phenol peeling belongs to a substantially higher-risk category and should never be treated as an ordinary escalation of a cosmetic facial.

I become more cautious when the barrier is inflamed, pigment behaviour is unstable, sun exposure cannot be controlled or the desired correction belongs to a structural layer that acid cannot reach.

Chemical peeling is powerful precisely because depth can be controlled.

The clinical standard is knowing when not to make it deeper.

Frequently asked questions

What is a chemical peel?

It is a controlled resurfacing procedure in which a chemical agent creates a planned degree of epidermal and sometimes dermal injury, followed by healing and tissue renewal.

What is the difference between a superficial, medium and deep peel?

The categories refer primarily to treatment depth. Deeper peels can create more substantial remodelling but require greater recovery and carry higher risks of pigment change, infection and scarring.

Is a stronger percentage always better?

No. Effective depth also depends on the specific acid, pH, formulation, application method, skin preparation and patient biology. Percentage alone is not a complete measure of treatment strength.

What is glycolic acid peeling used for?

Glycolic acid is commonly used for selected superficial pigmentation, texture, acne-related concerns and photoaging. It has a substantial clinical evidence base as a superficial peeling agent.

What is salicylic acid peeling used for?

Its lipid-soluble properties make salicylic acid particularly useful in selected oily, comedonal and acne-prone skin.

What is TCA peeling?

Trichloroacetic acid is a chemical peeling agent that can create superficial or more substantial resurfacing depending on how treatment is designed. Greater effective depth means greater recovery and complication risk.

What is a phenol peel?

Phenol is used in deep chemical peeling for selected severe photoaging and rhytids. It is a major medical resurfacing procedure with systemic toxicity concerns, including well-recognised cardiac risk, and should not be treated as a routine cosmetic peel.

Can chemical peels help acne?

Yes. Selected superficial peels can improve comedonal acne and support treatment of some inflammatory and pigmentary components. Significant active acne may still require established medical therapy.

Can chemical peels treat melasma?

They can be effective adjuncts in selected patients. Melasma remains chronic and recurrent, so photoprotection and topical pigment management usually remain central.

Are chemical peels safe for darker skin?

Superficial peels can be used successfully in skin of colour with appropriate selection. The increased importance of post-inflammatory hyperpigmentation makes conservative depth and inflammatory control particularly important.

Can chemical peeling remove acne scars?

It can improve selected superficial scar texture, and focal chemical techniques can be useful for specific narrow scars. Tethered or deeper scar architecture may require another treatment mechanism.

Does my skin need to visibly peel for the treatment to work?

No. Visible flaking varies with treatment type and depth. Clinical benefit does not require dramatic shedding.

How many peels do I need?

There is no universal number. Superficial conditions may be treated in stages, while deeper treatments follow another schedule. I prefer treatment number to follow response rather than a package.

When would you recommend no chemical peel?

I would postpone or redirect treatment when the skin barrier is unstable, active infection or significant inflammation is present, pigment risk is disproportionate to the expected benefit or the desired change requires another anatomical treatment category.